$SENS
Senseonics Holdings, Inc.

2024 Q4 Form 10-Q Financial Statement

#000155837024014878 Filed on November 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $4.263M
YoY Change -30.08%
Cost Of Revenue $8.314M
YoY Change 68.81%
Gross Profit -$4.051M
YoY Change -437.58%
Gross Profit Margin -95.03%
Selling, General & Admin $8.250M
YoY Change 11.11%
% of Gross Profit
Research & Development $10.55M
YoY Change -17.41%
% of Gross Profit
Depreciation & Amortization $196.0K
YoY Change 4.81%
% of Gross Profit
Operating Expenses $18.80M
YoY Change -6.92%
Operating Profit -$22.85M
YoY Change 20.11%
Interest Expense -$1.123M
YoY Change -146.31%
% of Operating Profit
Other Income/Expense, Net -$1.129M
YoY Change -77.78%
Pretax Income -$23.98M
YoY Change -0.53%
Income Tax
% Of Pretax Income
Net Earnings -$23.98M
YoY Change -0.53%
Net Earnings / Revenue -562.42%
Basic Earnings Per Share -$0.04
Diluted Earnings Per Share -$0.04
COMMON SHARES
Basic Shares Outstanding 592.6M 535.6M
Diluted Shares Outstanding 620.9M

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $74.48M
YoY Change -40.61%
Cash & Equivalents $27.11M
Short-Term Investments $47.38M
Other Short-Term Assets
YoY Change
Inventory $3.207M
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $87.70M
YoY Change -39.99%
LONG-TERM ASSETS
Property, Plant & Equipment $3.424M
YoY Change 266.6%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $8.633M
YoY Change 8.93%
TOTAL ASSETS
Total Short-Term Assets $87.70M
Total Long-Term Assets $8.633M
Total Assets $96.33M
YoY Change -37.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.107M
YoY Change -21.06%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $35.51M
YoY Change 105.23%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities $5.899M
YoY Change -6.54%
Total Long-Term Liabilities $5.899M
YoY Change -6.54%
TOTAL LIABILITIES
Total Short-Term Liabilities $35.51M
Total Long-Term Liabilities $5.899M
Total Liabilities $75.86M
YoY Change 17.89%
SHAREHOLDERS EQUITY
Retained Earnings -$932.4M
YoY Change 9.42%
Common Stock $546.0K
YoY Change 3.41%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$17.18M
YoY Change
Total Liabilities & Shareholders Equity $96.33M
YoY Change -37.47%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$23.98M
YoY Change -0.53%
Depreciation, Depletion And Amortization $196.0K
YoY Change 4.81%
Cash From Operating Activities -$14.82M
YoY Change -14.19%
INVESTING ACTIVITIES
Capital Expenditures -$203.0K
YoY Change -265.04%
Acquisitions
YoY Change
Other Investing Activities $3.119M
YoY Change -88.77%
Cash From Investing Activities $3.322M
YoY Change -87.98%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.743M
YoY Change -77.75%
NET CHANGE
Cash From Operating Activities -14.82M
Cash From Investing Activities 3.322M
Cash From Financing Activities 3.743M
Net Change In Cash -7.750M
YoY Change -128.48%
FREE CASH FLOW
Cash From Operating Activities -$14.82M
Capital Expenditures -$203.0K
Free Cash Flow -$14.61M
YoY Change -15.96%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://www.senseonics.com/20240930#AccruedLiabilitiesAndOtherLiabilitiesCurrent
CY2023Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://www.senseonics.com/20240930#AccruedLiabilitiesAndOtherLiabilitiesCurrent
dei Entity Central Index Key
EntityCentralIndexKey
0001616543
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
530364237
CY2024Q3 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://www.senseonics.com/20240930#DepositsAndOtherAssetsNoncurrent
CY2023Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://www.senseonics.com/20240930#DepositsAndOtherAssetsNoncurrent
CY2024Q3 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://www.senseonics.com/20240930#AccruedLiabilitiesAndOtherLiabilitiesCurrent
CY2023Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://www.senseonics.com/20240930#AccruedLiabilitiesAndOtherLiabilitiesCurrent
CY2024Q3 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent
CY2023Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent
CY2024Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
12000
CY2023Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
12000
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
545612780
us-gaap Debt Instrument Variable Interest Rate Type Extensible Enumeration
DebtInstrumentVariableInterestRateTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#PrimeRateMember
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37717
dei Entity Registrant Name
EntityRegistrantName
Senseonics Holdings, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-1210911
dei Entity Address Address Line1
EntityAddressAddressLine1
20451 Seneca Meadows Parkway
dei Entity Address City Or Town
EntityAddressCityOrTown
Germantown
dei Entity Address State Or Province
EntityAddressStateOrProvince
MD
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
20876-7005
dei City Area Code
CityAreaCode
301
dei Local Phone Number
LocalPhoneNumber
515-7260
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value
dei Trading Symbol
TradingSymbol
SENS
dei Security Exchange Name
SecurityExchangeName
NYSEAMER
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
592626155
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27106000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
75709000
CY2024Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
315000
CY2024Q3 us-gaap Short Term Investments
ShortTermInvestments
47375000
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
33747000
CY2024Q3 us-gaap Inventory Net
InventoryNet
3207000
CY2023Q4 us-gaap Inventory Net
InventoryNet
8776000
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5665000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7266000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
87698000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
130030000
CY2024Q3 sens Deposits And Other Assets Noncurrent
DepositsAndOtherAssetsNoncurrent
5209000
CY2023Q4 sens Deposits And Other Assets Noncurrent
DepositsAndOtherAssetsNoncurrent
7006000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3424000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1184000
CY2024Q3 us-gaap Assets
Assets
96331000
CY2023Q4 us-gaap Assets
Assets
138220000
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2107000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4568000
CY2024Q3 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
19376000
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
35509000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
17257000
CY2024Q3 us-gaap Long Term Debt
LongTermDebt
34448000
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
41195000
CY2023Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
102000
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5899000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6214000
CY2024Q3 us-gaap Liabilities
Liabilities
75856000
CY2023Q4 us-gaap Liabilities
Liabilities
64768000
CY2024Q3 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
12000
CY2023Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
12000
CY2024Q3 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
12000
CY2023Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
12000
CY2024Q3 us-gaap Temporary Equity Value Excluding Additional Paid In Capital
TemporaryEquityValueExcludingAdditionalPaidInCapital
37656000
CY2023Q4 us-gaap Temporary Equity Value Excluding Additional Paid In Capital
TemporaryEquityValueExcludingAdditionalPaidInCapital
37656000
CY2024Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
37656000
CY2023Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
37656000
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1400000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
900000000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
545612780
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
530364237
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
546000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
530000
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
914637000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
904535000
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
34000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-11000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-932398000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-869258000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-17181000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
35796000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
96331000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
138220000
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4263000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6097000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14175000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14360000
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
8314000
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4925000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
17593000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
12358000
CY2024Q3 us-gaap Gross Profit
GrossProfit
-4051000
CY2023Q3 us-gaap Gross Profit
GrossProfit
1172000
us-gaap Gross Profit
GrossProfit
-3418000
us-gaap Gross Profit
GrossProfit
2002000
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10546000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12769000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
31784000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
38003000
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8250000
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7425000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
25369000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
22598000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-22847000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-19022000
us-gaap Operating Income Loss
OperatingIncomeLoss
-60571000
us-gaap Operating Income Loss
OperatingIncomeLoss
-58599000
CY2024Q3 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
1010000
CY2023Q3 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
1460000
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
3584000
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
3879000
CY2023Q3 sens Nonoperating Gain Loss Exchanges
NonoperatingGainLossExchanges
-4569000
sens Nonoperating Gain Loss Exchanges
NonoperatingGainLossExchanges
14207000
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
2133000
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
2425000
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
6266000
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
9388000
CY2023Q3 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
438000
us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
102000
us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
6505000
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-6000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
15000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
11000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
194000
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1129000
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5081000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2569000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
15397000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-23976000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-24103000
us-gaap Net Income Loss
NetIncomeLoss
-63140000
us-gaap Net Income Loss
NetIncomeLoss
-43202000
CY2024Q3 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
41000
CY2023Q3 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
61000
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
45000
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
619000
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
41000
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
61000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
45000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
619000
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-23935000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-24042000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-63095000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-42583000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
620897955
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
592452262
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
617370311
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
552703546
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
620897955
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
592452262
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
617370311
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
552703546
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
52537000
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
118000
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5000
CY2023Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
21002000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
363000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
2084000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-24103000
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
61000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
52065000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-2576000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
7376000
sens Issued Common Stock For Vested Rsus And Espp Purchase
IssuedCommonStockForVestedRsusAndEsppPurchase
205000
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
63645000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3000
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
21002000
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
6735000
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1603000
us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-137000
us-gaap Net Income Loss
NetIncomeLoss
-43202000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
619000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
52065000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
578000
CY2024Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3667000
CY2024Q3 sens Issued Common Stock For Vested Rsus And Espp Purchase
IssuedCommonStockForVestedRsusAndEsppPurchase
76000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
1000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
2432000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-23976000
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
41000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-17181000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
35796000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3667000
sens Issued Common Stock For Vested Rsus And Espp Purchase
IssuedCommonStockForVestedRsusAndEsppPurchase
177000
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
149000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6000
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
7160000
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1041000
us-gaap Net Income Loss
NetIncomeLoss
-63140000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
45000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-17181000
us-gaap Profit Loss
ProfitLoss
-63140000
us-gaap Profit Loss
ProfitLoss
-43202000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
709000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
641000
sens Amortization Of Financing Costs Discounts And Deferred Costs
AmortizationOfFinancingCostsDiscountsAndDeferredCosts
2828000
sens Amortization Of Financing Costs Discounts And Deferred Costs
AmortizationOfFinancingCostsDiscountsAndDeferredCosts
6581000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
960000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
2253000
sens Fair Value Adjustment Derivative Liability
FairValueAdjustmentDerivativeLiability
-102000
sens Fair Value Adjustment Derivative Liability
FairValueAdjustmentDerivativeLiability
-6505000
sens Nonoperating Gain Loss Exchanges
NonoperatingGainLossExchanges
14207000
us-gaap Share Based Compensation
ShareBasedCompensation
7160000
us-gaap Share Based Compensation
ShareBasedCompensation
6735000
us-gaap Inventory Write Down
InventoryWriteDown
4203000
us-gaap Inventory Write Down
InventoryWriteDown
89000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-5000
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
488000
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
56000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-425000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
998000
sens Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
-1056000
sens Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
129000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1909000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2509000
sens Increase Decrease In Deposit Assets And Other Assets
IncreaseDecreaseInDepositAssetsAndOtherAssets
-1542000
sens Increase Decrease In Deposit Assets And Other Assets
IncreaseDecreaseInDepositAssetsAndOtherAssets
342000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2947000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
669000
sens Increase Decrease In Accrued Liabilities And Other Current Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities
1483000
sens Increase Decrease In Accrued Liabilities And Other Current Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities
1161000
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-192000
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-292000
sens Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-681000
sens Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-596000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-46219000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-55096000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
2205000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
180000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
58018000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
68537000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
45395000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
122235000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-14828000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
53518000
sens Proceeds From Issuance Of Common Stock Net
ProceedsFromIssuanceOfCommonStockNet
3667000
sens Proceeds From Issuance Of Common Stock Net
ProceedsFromIssuanceOfCommonStockNet
7376000
sens Proceeds From Exercise Of Stock Options Rs Us And Espp Net
ProceedsFromExerciseOfStockOptionsRSUsAndEsppNet
183000
sens Proceeds From Exercise Of Stock Options Rs Us And Espp Net
ProceedsFromExerciseOfStockOptionsRSUsAndEsppNet
71000
us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
9950000
us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
24446000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1041000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1603000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
244000
sens Proceeds From Issuance Of Warrants Net
ProceedsFromIssuanceOfWarrantsNet
14698000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12759000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
21544000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-48288000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
19966000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
75709000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
35793000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
27421000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
55759000
us-gaap Interest Paid Net
InterestPaidNet
3630000
us-gaap Interest Paid Net
InterestPaidNet
3100000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3831000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
466000
sens Issuance Of Warrant In Exchange For Phc Notes
IssuanceOfWarrantInExchangeForPhcNotes
48564000
sens Issuance Of Warrants For Loan And Security Agreement
IssuanceOfWarrantsForLoanAndSecurityAgreement
149000
sens Issuance Of Warrants For Loan And Security Agreement
IssuanceOfWarrantsForLoanAndSecurityAgreement
364000
us-gaap Stock Issued1
StockIssued1
21002000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-60400000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
142100000
us-gaap Gross Profit
GrossProfit
-3400000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-932400000
CY2024Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
74500000
CY2024Q4 sens Management Services Agreements Term
ManagementServicesAgreementsTerm
P10Y
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the reported amounts of revenue and expenses during the reporting period. In the accompanying unaudited consolidated financial statements, estimates are used for, but not limited to, stock-based compensation, recoverability of long-lived assets, deferred taxes and valuation allowances, fair value of investments, derivative assets and liabilities, obsolete inventory, warranty obligations, variable consideration related to revenue, allowance for credit losses, depreciable lives of property and equipment, and accruals for clinical study costs, which are accrued based on estimates of work performed under contract. The Company bases these estimates on historical and anticipated results, trends, and various other assumptions that it believes are reasonable, including assumptions as to future events. These estimates form the basis for making judgments about the carrying values of assets and liabilities and recorded revenues and expenses. Actual results could differ from those estimates; however, management does not believe that such differences would be material.</p>
sens Number Of Geographical Markets
NumberOfGeographicalMarkets
2
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4263000
CY2024Q3 sens Revenue By Geographical Region Percentage
RevenueByGeographicalRegionPercentage
1.000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14175000
sens Revenue By Geographical Region Percentage
RevenueByGeographicalRegionPercentage
1.000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6097000
CY2023Q3 sens Revenue By Geographical Region Percentage
RevenueByGeographicalRegionPercentage
1.000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14360000
sens Revenue By Geographical Region Percentage
RevenueByGeographicalRegionPercentage
1.000
CY2024Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
500000
CY2023Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
1500000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-23976000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-24103000
us-gaap Net Income Loss
NetIncomeLoss
-63140000
us-gaap Net Income Loss
NetIncomeLoss
-43202000
CY2024Q3 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
-23976000
CY2023Q3 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
-24103000
us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
-63140000
us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
-43202000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
620897955
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
592452262
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
617370311
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
552703546
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
620897955
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
592452262
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
617370311
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
552703546
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
92034866
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
79208079
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
92034866
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
79208079
CY2024Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
47341000
CY2024Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
34000
CY2024Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
47375000
CY2023Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
33758000
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1000
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
12000
CY2023Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
33747000
CY2024Q3 us-gaap Available For Sale Securities Debt Maturities Remainder Of Fiscal Year Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis
47341000
CY2024Q3 us-gaap Available For Sale Securities Debt Maturities Remainder Of Fiscal Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue
47375000
CY2024Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
47341000
CY2024Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
47375000
CY2024Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
798000
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
2160000
CY2024Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2157000
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
5332000
CY2024Q3 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
252000
CY2023Q4 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
1284000
CY2024Q3 us-gaap Inventory Net
InventoryNet
3207000
CY2023Q4 us-gaap Inventory Net
InventoryNet
8776000
CY2024Q3 sens Prepaid Contract Manufacturing Current
PrepaidContractManufacturingCurrent
2526000
CY2023Q4 sens Prepaid Contract Manufacturing Current
PrepaidContractManufacturingCurrent
4244000
CY2024Q3 sens Tax Credits Receivable
TaxCreditsReceivable
1793000
CY2023Q4 sens Tax Credits Receivable
TaxCreditsReceivable
1793000
CY2024Q3 sens Prepaid Clinical And Preclinical Costs
PrepaidClinicalAndPreclinicalCosts
451000
CY2023Q4 sens Prepaid Clinical And Preclinical Costs
PrepaidClinicalAndPreclinicalCosts
343000
CY2024Q3 sens Prepaid Information Technology And Software Costs Current
PrepaidInformationTechnologyAndSoftwareCostsCurrent
309000
CY2023Q4 sens Prepaid Information Technology And Software Costs Current
PrepaidInformationTechnologyAndSoftwareCostsCurrent
242000
CY2024Q3 us-gaap Prepaid Insurance
PrepaidInsurance
306000
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
73000
CY2024Q3 sens Prepaid Accounting And Audit
PrepaidAccountingAndAudit
157000
CY2023Q4 sens Prepaid Accounting And Audit
PrepaidAccountingAndAudit
61000
CY2024Q3 us-gaap Prepaid Rent
PrepaidRent
99000
CY2023Q4 us-gaap Prepaid Rent
PrepaidRent
122000
CY2024Q3 us-gaap Prepaid Advertising
PrepaidAdvertising
23000
CY2023Q4 us-gaap Prepaid Advertising
PrepaidAdvertising
20000
CY2023Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
272000
CY2023Q4 sens Research And Development
ResearchAndDevelopment
95000
CY2024Q3 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
1000
CY2023Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
1000
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5665000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7266000
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3931000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4799000
CY2024Q3 sens Accrued Research And Development Current
AccruedResearchAndDevelopmentCurrent
3536000
CY2023Q4 sens Accrued Research And Development Current
AccruedResearchAndDevelopmentCurrent
3846000
CY2024Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2143000
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
673000
CY2024Q3 sens Accrued Contract Manufacturing Costs Current
AccruedContractManufacturingCostsCurrent
1797000
CY2023Q4 sens Accrued Contract Manufacturing Costs Current
AccruedContractManufacturingCostsCurrent
1457000
CY2024Q3 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
855000
CY2023Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
301000
CY2024Q3 us-gaap Interest Payable Current
InterestPayableCurrent
512000
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
704000
CY2024Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
415000
CY2023Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
514000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
413000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
368000
CY2024Q3 sens Accrued Construction And Renovation Costs Current
AccruedConstructionAndRenovationCostsCurrent
397000
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
27000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
27000
CY2024Q3 sens Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
14026000
CY2023Q4 sens Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
12689000
us-gaap Operating Lease Expense
OperatingLeaseExpense
700000
us-gaap Operating Lease Expense
OperatingLeaseExpense
600000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4925000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5180000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
413000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
368000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5899000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6214000
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
6312000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
6582000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
231000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
939000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
967000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
996000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1026000
CY2024Q3 sens Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
4908000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
9067000
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2755000
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
6312000
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y8M12D
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.085
sens Product Warranty Term
ProductWarrantyTerm
P1Y
CY2024Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
400000
CY2023Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
500000
CY2023Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
514000
CY2022Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
781000
us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
177000
CY2023 us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
242000
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
276000
CY2023 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
509000
CY2024Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
415000
CY2023Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
514000
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
3438000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2734000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
94000
us-gaap Interest Expense Debt
InterestExpenseDebt
6266000
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
2808000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
6408000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
172000
us-gaap Interest Expense Debt
InterestExpenseDebt
9388000
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
20399000
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
12996000
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
24437000
CY2024Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
57832000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001558370-24-014878-index-headers.html Edgar Link pending
0001558370-24-014878-index.html Edgar Link pending
0001558370-24-014878.txt Edgar Link pending
0001558370-24-014878-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sens-20240930.xsd Edgar Link pending
sens-20240930x10q.htm Edgar Link pending
sens-20240930xex31d1.htm Edgar Link pending
sens-20240930xex31d2.htm Edgar Link pending
sens-20240930xex32d1.htm Edgar Link pending
Show.js Edgar Link pending
sens-20240930_def.xml Edgar Link unprocessable
sens-20240930_lab.xml Edgar Link unprocessable
sens-20240930_pre.xml Edgar Link unprocessable
sens-20240930x10q_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
sens-20240930_cal.xml Edgar Link unprocessable